Forbion closes €2.3bn across two life sciences funds
Forbion has secured €2.3 billion across a pair of venture vehicles, handing the Dutch firm fresh dry powder at a moment when European biotech founders
Solstice Oncology
Every Fin-node story mentioning Solstice Oncology — 1 story, newest first.
Solstice Oncology · 1 story